• Eric Topol’s Top Targets for Wireless Medicine

    Sidebar: Lauren Phillips Apr 27, 2016

    Alzheimer's disease (5 million Americans). Wireless devices can track the vital signs of patients as well as their location, activity, and balance; smartphone apps can track specific eye function; and other apps can perform cognitive tests for screening, diagnosing, and monitoring the condition.

    Asthma (20 million). Wireless devices can track respiratory rate, peak flow, lung function, air quality, pollen count, and other triggers so patients can preempt attacks before the onset of symptoms.

    Chronic obstructive pulmonary disorder (10 million). Wireless devices can monitor FEV1 (forced expiratory volume, a common index used to assess airway obstruction), air quality, and oximetry.

    Depression (19 million). Wireless devices can monitor activity, communication patterns, tone and inflection of voice, facial recognition, vital signs, breathing patterns, galvanic skin response, and medication compliance.

    Diabetes (21 million). Wireless devices can monitor blood glucose and hemoglobin.

    Heart failure (5 million). Wireless devices can monitor vital signs, cardiac output and pressures, and chest fluid.

    Hypertension (74 million). Wireless devices can continuously monitor blood pressure and track medication compliance.

    Obesity (80 million). Wireless devices can track weight, and wireless smartphone sensors are being developed to scan food for caloric and nutritional content.

    Sleep apnea and disorders: (15 million). Wireless sensors can monitor each of the phases of sleep for quality of rest, detect apnea, and track vital signs.